Comparison of Surgical Septal Myectomy and Alcohol Septal Ablation With Cardiac Magnetic Resonance Imaging in Patients With Hypertrophic Obstructive Cardiomyopathy

Journal of the American College of Cardiology

Volumn 49, Issue 3, 2007, Pages 350-357

  Valeti, Uma S ^a   Nishimura, Rick A ^a   Holmes, David R ^a   Araoz, Philip A ^a   Glockner, James F ^a   Breen, Jerome F ^a   Ommen, Steve R ^a   Gersh, Bernard J ^a   Tajik, A Jamil ^a   Rihal, Charanjit S ^a   Schaff, Hartzell V ^a   Maron, Barry J ^b  

^a MAYO CLINIC   (United States)

^b MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALCOHOL SEPTAL ABLATION; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE NECROSIS; HEART SURGERY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERMETHOD COMPARISON; MUSCLE RESECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; SURGICAL SEPTAL MYECTOMY; TREATMENT OUTCOME;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CHI-SQUARE DISTRIBUTION; ETHANOL; FEMALE; FOLLOW-UP STUDIES; HEART SEPTUM; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 33846244648     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.08.055     Document Type: Article

References (27)

1. Nishimura R.A., and Holmes Jr. D.R. Clinical practice. Hypertrophic obstructive cardiomyopathy. N Engl J Med 350 (2004) 1320-1327
2. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
3. Maron B.J., Dearani J.A., Ommen S.R., et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 44 (2004) 2044-2053
4. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 (2003) 1687-1713
5. Ommen S.R., Maron B.J., Olivotto I., et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46 (2005) 470-476
6. Seggewiss H., Gleichmann U., Faber L., Fassbender D., Schmidt H.K., and Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 31 (1998) 252-258
7. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346 (1995) 211-214
8. Kuhn H., Gietzen F.H., Leuner C., et al. Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol 89 (2000) IV41-IV54
9. Hess O.M., and Sigwart U. New treatment strategies for hypertrophic obstructive cardiomyopathy: alcohol ablation of the septum: the new gold standard?. J Am Coll Cardiol 44 (2004) 2054-2055
10. Morrow A.G., Roberts W.C., Ross Jr. J., et al. Obstruction to left ventricular outflow. Current concepts of management and operative treatment. Ann Intern Med 69 (1968) 1255-1286
11. Talreja D.R., Nishimura R.A., Edwards W.D., et al. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol 44 (2004) 2329-2332
12. Ommen S.R., Park S.H., Click R.L., Freeman W.K., Schaff H.V., and Tajik A.J. Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy. Am J Cardiol 90 (2002) 1022-1024
13. Nagueh S.F., Lakkis N.M., He Z.X., et al. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 32 (1998) 225-229
14. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 (2001) 215-223
15. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
16. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
17. Choudhury L., Mahrholdt H., Wagner A., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
18. van Dockum W.G., Beek A.M., ten Cate F.J., et al. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111 (2005) 2503-2508
19. van Dockum W.G., ten Cate F.J., ten Berg J.M., et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43 (2004) 27-34
20. Seggewiss H., Faber L., and Gleichmann U. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg 47 (1999) 94-100
21. Qin J.X., Shiota T., Lever H.M., et al. Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol 93 (2004) 171-175
22. McCully R.B., Nishimura R.A., Tajik A.J., Schaff H.V., and Danielson G.K. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 94 (1996) 467-471
23. Maron B.J. Surgery for hypertrophic obstructive cardiomyopathy: alive and quite well. Circulation 111 (2005) 2016-2018
24. Boltwood Jr. C.M., Chien W., and Ports T. Ventricular tachycardia complicating alcohol septal ablation. N Engl J Med 351 (2004) 1914-1915
25. McGregor J.B., Rahman A., Rosanio S., Ware D., Birnbaum Y., and Saeed M. Monomorphic ventricular tachycardia: a late complication of percutaneous alcohol septal ablation for hypertrophic cardiomyopathy. Am J Med Sci 328 (2004) 185-188
26. Kuhn H., Seggewiss H., Gietzen F.H., Boekstegers P., Neuhaus L., and Seipel L. Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry. Z Kardiol 93 (2004) 23-31
27. Nagueh S.F., Ommen S.R., Lakkis N.M., et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 38 (2001) 1701-1706